1. Home
  2. ALBT vs JCSE Comparison

ALBT vs JCSE Comparison

Compare ALBT & JCSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALBT
  • JCSE
  • Stock Information
  • Founded
  • ALBT 2014
  • JCSE 1999
  • Country
  • ALBT United States
  • JCSE Singapore
  • Employees
  • ALBT N/A
  • JCSE N/A
  • Industry
  • ALBT Biotechnology: Biological Products (No Diagnostic Substances)
  • JCSE Miscellaneous manufacturing industries
  • Sector
  • ALBT Health Care
  • JCSE Consumer Discretionary
  • Exchange
  • ALBT Nasdaq
  • JCSE Nasdaq
  • Market Cap
  • ALBT 5.3M
  • JCSE 6.3M
  • IPO Year
  • ALBT N/A
  • JCSE 2022
  • Fundamental
  • Price
  • ALBT $3.68
  • JCSE $1.18
  • Analyst Decision
  • ALBT
  • JCSE
  • Analyst Count
  • ALBT 0
  • JCSE 0
  • Target Price
  • ALBT N/A
  • JCSE N/A
  • AVG Volume (30 Days)
  • ALBT 15.5K
  • JCSE 729.7K
  • Earning Date
  • ALBT 05-13-2025
  • JCSE 05-15-2025
  • Dividend Yield
  • ALBT N/A
  • JCSE 7.62%
  • EPS Growth
  • ALBT N/A
  • JCSE N/A
  • EPS
  • ALBT N/A
  • JCSE 0.00
  • Revenue
  • ALBT $807,235.00
  • JCSE $14,126,397.00
  • Revenue This Year
  • ALBT N/A
  • JCSE N/A
  • Revenue Next Year
  • ALBT N/A
  • JCSE N/A
  • P/E Ratio
  • ALBT N/A
  • JCSE $256.96
  • Revenue Growth
  • ALBT N/A
  • JCSE 6.92
  • 52 Week Low
  • ALBT $2.11
  • JCSE $0.70
  • 52 Week High
  • ALBT $21.60
  • JCSE $2.39
  • Technical
  • Relative Strength Index (RSI)
  • ALBT 44.78
  • JCSE 52.18
  • Support Level
  • ALBT $3.61
  • JCSE $1.11
  • Resistance Level
  • ALBT $3.79
  • JCSE $1.26
  • Average True Range (ATR)
  • ALBT 0.17
  • JCSE 0.13
  • MACD
  • ALBT 0.02
  • JCSE -0.01
  • Stochastic Oscillator
  • ALBT 34.71
  • JCSE 16.35

About ALBT Avalon GloboCare Corp.

Avalon Globocare Corp is an intelligent biotech developer and healthcare service provider dedicated to promoting and empowering high-impact, transformative biotechnology, clinical applications, and healthcare facility management. The company has two reportable segments: the real property operating segment, which is the key revenue driver, and the laboratory testing services segment. The company focuses on diagnostic and therapeutic areas like early detection of oral cancer, ovarian cancer, kidney cancer, skin regeneration and anti-fibrosis, and treatments of degenerative disorders.

About JCSE JE Cleantech Holdings Limited

JE Cleantech Holdings Ltd is engaged in the manufacturing and selling of cleaning systems and other equipment that can be categorized into four different categories, namely aqueous washing systems, plating and cleaning systems, train cleaning systems, and other equipment, such as filtration units. The product lives of its cleaning systems and other equipment range from two to ten years. The company is also into designing, developing, and manufacturing other cleaning systems for various industrial end-use applications using its R&D and engineering capabilities. It derives a majority of its revenue from Singapore.

Share on Social Networks: